Spotlight Features
Al Lewy, M.D., Ph.D.
About 100,000 blind people in the United States suffer from sleep disorders caused by their brains’ inability to distinguish between darkness and light. In the early 1980s, Al Lewy, M.D., Ph.D., Professor in the Department of Psychiatry, established that exposure to bright light can reset out-of-phase body clocks in the sighted.
Read More
Anh Nguyen-Huynh, M.D., Ph.D.
Affecting roughly half a million Americans, Meniere’s Disease is a disorder of the inner ear, causing episodic attacks of vertigo, nausea and vomiting, tinnitus and fluctuating hearing loss. Meniere’s disease tends to afflict people over 40 years old.
Read More
Billy Martin, Ph.D.
Billy Martin, Ph.D., splits his professional life in several ways. Much of the time he is working with those who suffer from chronic, disabling tinnitus (ringing in the ears). He is also working with colleagues trying to figure out how to shut off this frequently debilitating sound .
Read More
Charles Springer, Ph.D.
Charles Springer, Ph.D., and multi-disciplinary collaborators are developing a new breast cancer screening method that can reduce or eliminate unnecessary biopsy surgeries.
Read More
Cheryl Maslen, Ph.D.
Genetics has fascinated Cheryl Maslen, Ph.D.'87, since the very earliest stages of her academic career. Lately, her focus has been on the Down syndrome (DS) population as a potential avenue to uncovering genetic factors causing heart defects in the general population.
Read More
Garet Lahvis, Ph.D.
A research team led by Garet Lahvis, Ph.D., Assistant Professor of Behavioral Neuroscience, recently showed that a strain of mice known as B6 is capable of empathy towards other distressed mice.
Read More
K. John McConnell, Ph.D.
K. John McConnell, Ph.D., Assistant Professor in the Department of Emergency Medicine, was a familiar face in the legislative corridors of Salem in the most recent legislative session. Dr. McConnell, a health economist, acted as Chief Economic Advisor to the Oregon Health Fund Board
Read More
Linn Goldberg, M.D.
A Q & A with Dr. Linn Goldberg on anabolic steroid use. Once limited to professional and Olympic athletes, it has now invaded high school sports.
Read More
Margo Haygood, Ph.D.
The National Institutes of Health has awarded $4 million to a group of Philippine and American scientists to aid in the discovery of new molecules and biofuels technology from marine mollusks for development in the Philippines.
Read More
Mary Stenzel-Poore, Ph.D.
Immunologists typically focus their intellectual attention on viruses, bacteria, and parasites, and how these organisms interact with and evade the immune system. Mary Stenzel-Poore, Ph.D., interim Chair of the Department of Molecular Microbiology & Immunology, is interested in how the immune system affects the body’s response to injury and repair.
Read More
Maureen Hoatlin, Ph.D.
An editorial in the journal Nature Genetics called the study of Fanconi anemia a "tough and simultaneously scientifically rewarding problem." Maureen Hoatlin, Ph.D., Associate Professor, Department of Biochemistry and Molecular Medicine, agrees wholeheartedly.
Read More
Mike Bonazzola, M.D.
People without insurance rely on low-cost community safety net clinics for primary care, but when acute or specialty care needs arise, uninsured people face daunting obstacles. As part of Project Access NOW, physicians across the Portland and Vancouver metro area have come together to help partly alleviate this problem.
Read More
Miles Novy, M.D.
Miles Novy, M.D., observes that every decade since his arrival in Oregon in 1970, "has marked a very important step forward at OHSU in building the research mission. Now, as I look into the future, I see the next big opportunity to be a concerted effort to consolidate and transform this growth and the associated knowledge accumulation into new benefits for women’s health."
Read More
Misha Pavel, Ph.D.
Misha Pavel, Ph.D., new Division Head, charts a course to a future where biomedical engineering stands shoulder to shoulder with clinical care.
Read More
Peter Kurre, M.D.
For years, the potential of using engineered viruses in gene therapy has held out great therapeutic promise while also presenting significant obstacles. Chief among the obstacles is the body's own multifaceted immune response.
Read More
Rosalie Sears, Ph.D.
The c-Myc oncogene, regularly highly-expressed in most human tumors, has long been of interest to researchers seeking therapeutic targets for cancer treatments. Rosalie Sears, Ph.D., Associate Professor in the Department of Molecular and Medical Genetics, is pursuing a road-less- traveled in her research on this oncogene by focusing her attention on the post-translational regulation of the c-Myc oncoprotein.
Read More
Stephen A. Back, M.D., Ph.D.
Stephen A. Back, M.D., Ph.D., Associate Professor, Department of Pediatrics, has been awarded a Javits Neuroscience Investigator Award (NINDS) for his pioneering work in the cellular and molecular cause(s) of brain injury in premature infants.
Read More
